RICHARD CHRISTOPHER Insider Trading
Get free email notifications about insider trading for RICHARD CHRISTOPHER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD CHRISTOPHER. RICHARD CHRISTOPHER is a CFO, EVP in ICAD INC ($ICAD) and an Executive VP and CFO in ICAD INC ($ICAD) and a VP Fin'l Plng & Bus. Analysis in DUSA PHARMACEUTICALS INC ($DUSA) and a VP Finance & CFO in DUSA PHARMACEUTICALS INC ($DUSA) and a CFO and Treasurer in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV).
Address: C/O DUSA PHARMACEUTICALS, INC. 25 UPTON DRIVE WILMINGTON 01887 MA
Companies in which RICHARD CHRISTOPHER is an Insider
DUSA PHARMACEUTICALS INC
Trading Symbol: DUSAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD CHRISTOPHER: VP Finance & CFO, VP Fin'l Plng & Bus. Analysis
Holdings: 0 shares
Latest Transaction: Dec 20 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ICAD INC
Trading Symbol: ICADIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of RICHARD CHRISTOPHER: Executive VP and CFO, CFO, EVP
Holdings: 117,854 shares
Current Value: $441,953
Latest Transaction: Dec 27 2018
$ICAD Market Capitalization: $59.53M
$ICAD Previous Close: $3.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INVIVO THERAPEUTICS HOLDINGS CORP.
Trading Symbol: NVIVIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of RICHARD CHRISTOPHER: CFO and Treasurer
Holdings: 5,220 shares
Current Value: $23,229
Latest Transaction: Mar 22 2021
$NVIV Market Capitalization: $139.34M
$NVIV Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RICHARD CHRISTOPHER
Sentiment: All, DUSA, ICAD, NVIV
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | P | 2.75 | 3,636 | 9,999 | 3,636 | |
Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Buy | P | 0.00 | 3,636 | 0 | 5,220 | 1.6 K to 5.2 K (+229.55 %) |
Sep 27 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Grant | A | 0.00 | 47,500 | 0 | 47,500 | 0 to 47.5 K |
Jan 16 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.53 | 90,000 | 137,700 | 90,000 | |
Jan 16 2019 | NVIV | INVIVO THERAPEUTIC ... | CHRISTOPHER RICHARD | CFO and Treasurer | Option Exercise | A | 1.53 | 90,000 | 137,700 | 90,000 | |
Dec 27 2018 | ICAD | ICAD INC | CHRISTOPHER RICHARD | Executive VP and CF ... | Option Exercise | A | 4.00 | 5,000 | 20,000 | 5,000 |